GLYCODATA

USPTO USPTO 2000 CANCELLED - SECTION 8

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die US-Marke GLYCODATA wurde als Wortmarke am 04.01.2000 beim Amerikanischen Patent- und Markenamt angemeldet.
Sie wurde am 03.12.2002 im Markenregister eingetragen. Der aktuelle Status der Marke ist "CANCELLED - SECTION 8".

Markendetails Letztes Update: 30. Juli 2019

Markenform Wortmarke
Aktenzeichen 75886709
Registernummer 2655357
Anmeldedatum 04. Januar 2000
Veröffentlichungsdatum 10. September 2002
Eintragungsdatum 03. Dezember 2002

Markeninhaber

3 HABOSEM STREET
KIRYAT MENRAV, ASHDOD
IL

Markenvertreter

Waren und Dienstleistungen

1 diagnostic preparations for scientific use; reagents for scientific use; biochemicals, namely glycomolecules binding agents for in vitro scientific use
5 Glycomolecules, biological and chemical preparations containing glycomolecules, for use in the medical, pharmaceutical and veterinary industries for use in the treatment of cancer, cardiovascular diseases, inflammatory central nervous system and immunological disorders, anemia and infectious diseases; cellulose esters for use in the pharmaceutical industry for use in the treatment of cancer, cardiovascular diseases, inflammatory central nervous system and immunological disorders, anemia and infectious diseases; dietetic food preparations for medical purposes; diagnostic preparations comprising glycomolecules for use in the medical, pharmaceutical and veterinary industries for use in the treatment of cancer, cardiovascular diseases, inflammatory central nervous system and immunological disorders, anemia and infectious diseases; diagnostic preparations for the detection of glycomolecules for use in the medical, pharmaceutical and veterinary industries for use in the treatment of cancer, cardiovascular diseases, inflammatory central nervous system and immunological disorders, anemia and infectious diseases; glycomolecules derived pharmaceutical preparations for the treatment of cardiovascular diseases and disorders, cancer, bone marrow transplantation, diseases and disorders of the immune system, diabetics and restenosis
9 Computer software and interfacing programs for experimental data storage retrieval, analysis and presentation for the determination of the structure and contents of chemical compounds, namely glycomolecules and instructional material sold integrally therewith
10 apparatus and instruments for use in medical analysis of glycomolecules, namely, microsopes, spectrum analysis devices, and biochips; medical implants comprising glycomolecules, namely, bone implants, vascular implants, neurologic implants, orthopedic implants, prosthesis, namely bone prosthesis, vascular prosthesis, neurologic prosthesis, orthopedic prosthesis, arterial prosthesis, surgical and arterial patches comprising artificial material
29 Glycomolecules for use as a food additive for non-nutritional purposes for use as a flavoring, ingredient or filler
42 Technical industrial research services, namely, analysis of glycomolecules; agricultural services, namely services for the identification of bacterial contaminants milk and milking equipment; scientific research services; consultancy services in the field of agrochemicals, analysis and synthesis of chemical compounds and food supplements
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

ID: 1375886709